Eden Research (LON:EDEN) Stock Price Down 3.3% – What’s Next?

Eden Research plc (LON:EDEN)’s share price fell 3.3% on Saturday . The company traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). 450,985 shares traded hands during trading, a decline of 52% from the average session volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Price Performance

The company has a current ratio of 3.80, a quick ratio of 2.42 and a debt-to-equity ratio of 1.26. The business has a 50-day moving average price of GBX 3.87 and a two-hundred day moving average price of GBX 3.95. The firm has a market capitalization of £18.56 million, a price-to-earnings ratio of -12.19 and a beta of 0.92.

Insider Buying and Selling

In other news, insider Alexander John Abrey purchased 540,540 shares of the firm’s stock in a transaction on Tuesday, January 28th. The stock was purchased at an average cost of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($27,362.19). Also, insider Lykele van der Broek acquired 256,000 shares of Eden Research stock in a transaction dated Thursday, February 6th. The shares were bought at an average cost of GBX 4 ($0.05) per share, with a total value of £10,240 ($12,958.74). Corporate insiders own 14.02% of the company’s stock.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.